Skip to main content

Table 8 Comparative IVIVC data for CGA, CGA 90H NPVs and CGA S100 NPVs

From: Chlorogenic acid-optimized nanophytovesicles: a novel approach for enhanced permeability and oral bioavailability

Time (h)

CGA (%)

CGA 90H NPVs (%)

CGA S100 NPVs (%)

In vitro released

In vivo absorbed

In vitro released

In vivo absorbed

In vitro released

In vivo absorbed

0

0

0

0

0

0

0

0.5

69.4 ± 1.45

25.55 ± 1.05

26.8 ± 1.21

26.09 ± 1.22

23.0 ± 1.34

24.32 ± 1.05

1

74.6 ± 1.23

25.35 ± 1.53

32.6 ± 1.49

26.58 ± 1.07

34.7 ± 1.18

23.76 ± 1.11

2

86.7 ± 1.75

25.06 ± 1.28

39.8 ± 1.07

26.53 ± 1.37

38.7 ± 1.25

23.70 ± 1.28

4

89.1 ± 1.31

24.86 ± 1.19

44.7 ± 0.26

26.45 ± 1.41

43.6 ± 1.05

23.44 ± 1.16

8

89.8 ± 1.39

24.81 ± 1.31

58.5 ± 1.02

26.38 ± 1.43

67.7 ± 1.27

23.31 ± 1.04

  1. Data were represented as mean ± SD (n = 5)